Skip to main content
logo
Bright Minds Biosciences Inc. (CSE:DRUG)
Canada flag Canada · Delayed Price · Currency is CAD
92.09
-2.19 (-2.32%)
Sep 4, 2026, 1:51 PM EST

Bright Minds Biosciences Ratios and Metrics

Millions CAD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
9305987828107
Market Cap Growth
143.13%9016.50%-19.09%-71.17%-73.71%-
Enterprise Value
622547001985
Last Close Price
94.2884.391.472.158.5045.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PB Ratio
3.027.291.191.232.675.51
P/TBV Ratio
3.027.291.191.232.675.52

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
00.000.020.010.01-
Net Debt / Equity Ratio
-1.00-1.01-1.01-1.01-1.09-1.02
Quick Ratio
121.4435.6810.9224.168.0031.12
Current Ratio
121.9736.1011.3224.268.1131.38
Return on Equity (ROE)
-13.63%-27.93%-46.18%-86.02%-99.95%-85.94%
Return on Assets (ROA)
-13.50%-18.80%-25.28%-47.45%-57.32%-51.52%
Return on Capital Employed (ROCE)
-12.70%-16.60%-47.10%-109.10%-138.80%-44.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-2.64%-2.04%-42.70%-90.90%-53.20%-8.09%
Buyback Yield / Dilution
-38.94%-59.58%-15.87%-50.58%-37.64%-148.42%